12204960.txt 0 use   egg yolkderived immunoglobulin   an alternative   antibiotic treatment   control   helicobacter pylori infection
12204960.txt 1   present study evaluated   potential use   immunoglobulin prepared     egg yolk   hens immunized   helicobacter pylori immunoglobulin y igyhp     treatment   h pylori infections   purity     purified igyhp was 913     yield   94 mg   igy per ml   egg yolk   titer   igyhp was 16 times higher than     igy   egg yolk   nonimmunized hens   igyhp significantly inhibited   growth   urease activity   h pylori   vitro bacterial adhesion   ags cells was definitely reduced   preincubation   both h pylori 108 cfuml   10 mg   igyhpml   mongolian gerbil models igyhp decreased h pyloriinduced gastric mucosal injury   determined     degree   lymphocyte   neutrophil infiltration therefore     experimental model h pyloriassociated gastritis could   successfully treated   orally administered igyhp   immunological activity   igyhp stayed active   60c   10 min suggesting   pasteurization can   applied   sterilize   product fortification   food products     immunoglobulin would significantly decrease   h pylori infection   conclusion   igyhp obtained   hens immunized   h pylori could provide   novel alternative approach   treatment   h pylori infection
12204960.txt 2 
12204960.txt 3 helicobacter pylori     most common cause   gastritis   gastric ulcers   plays   pivotal role     development   gastric carcinomas  often   significant portion   those infected     show symptoms although chronic infection increases   risk     development   h pyloriassociated gastric disease   have been tremendous efforts   evaluate numerous therapeutic regimens   eradication   h pylori infections successful treatment   h pylori infections most often employs antibiotic therapy consisting   some combination   metronidazole amoxicillin clarithromycin   either bismuth     proton pump inhibitor  however antibiotic therapy fails   10   15   cases due     development   antibiotic resistance  increasing occurrence   antibiotic resistance would further complicate   treatment   h pylori infections consequently     important   seek new therapies     wider means   treating suppressing   preventing h pylori infection without drug resistance problems   concept   protecting   host   passively derived antibodies     new   has been shown   oral administration   antibacterial   antiviral immunoglobulins through infant formulae   other diet   effective   preventing intestinal infection  however oral administration   antibodies   prohibitively expensive when large amounts   antibodies   required  recently chicken egg yolk was recognized   an inexpensive alternative antibody source     usefulness   egg yolk immunoglobulin y igy has been assessed   therapeutic application   passive immunization therapy through oral ingestion   igy     fortified food products   prevention   control   intestinal infections such   those caused   enterotoxigenic escherichia coli  salmonella enterica serovar typhimurium    rotavirus  these studies taken together provide   potential advantage   using igy   specificity   h pylori igyhp   controlling h pyloriassociated gastric disease   subsequently prevent disease resulting   chronic infection nevertheless   has been   report   far     use   igy     prevention   treatment   h pylori infections furthermore     practical application   igyhp together   food   pharmaceutical materials   prevent h pyloriassociated disease   stability   igy toward heat acid   pepsin should   ensured   aim     study was   evaluate   potential use   igyhp     prevention   treatment   h pylori infections   achieve   objective   studied   vitro     vivo   activity   igyhp against h pylori   effect   igyhp   gastric mucosal injury induced   h pylori was evaluated   vivo using mongolian gerbils   stability   igyhp was also investigated
12204960.txt 4 h pylori preparation   immunization  h pylori atcc 43504 was cultured   brucella broth difco laboratories detroit mich supplemented   5 volvol bovine calf serum paa laboratories inc parker ford pa   antibiotics amphotericin b 25 mugml vancomycin 10 mugml trimethoprim 5 mugml   polymyxin b 25 iuml   were   sigma chemical co st louis mo   37c under 10 co2   200 rpm   h pylori was harvested   centrifugation   12000 x g   10 min   disrupted   sonication cellular material was removed   centrifugation     supernatant was collected h pylori wholecell lysate   protein concentrations were determined   bicinchoninic acid methods pierce rockford ill brown leghorn hens 25 weeks old n  15 were immunized intramuscularly   h pylori wholecell lysate 200 mugml protein using an equal volume   freunds complete adjuvant difco laboratories each hen was injected   four different sites 250 mul per site     leg muscle three booster injections   freunds incomplete adjuvant were given   2week intervals following   first injection one month after immunization   eggs laid were collected daily   1 month   stored   4c   egg yolk was separated pooled   frozen prior   purification   igy  isolation   purification   igyhp  isolation   igyhp was carried out     method described   akita   nakai    modification egg yolk was separated     white     yolk preparation was mixed   an equal volume   distilled water   30 min followed     addition   015 wtvol lambdacarrageenan wako pure chemical laboratory osaka japan after centrifugation   10000 x g   20c   30 min   watersoluble fraction wsf was collected   filtered through   whatman filter paper   1   remove solid lipid materials   resulting igycontaining filtrate was further purified   salt precipitation 19 wtvol sodium sulfate   ultrafiltration uf using   uf membrane millipore corp bedford mass cartridge     molecular weight cutoff   100 kda purity   yield   igy were monitored   various stages   sodium dodecyl sulfatepolyacrylamide gel electrophoresis sdspage   igy content was measured   its absorbance   280 nm  sdspage  according     method   laemmli  10 page was done     miniprotean ii cell biorad laboratories hercules calif under nonreducing conditions samples were diluted 14   sample buffer 626 mm trishcl ph 68 25 volvol glycerol   2 sds volvol under reducing conditions samples were diluted   sample buffer containing 5 volvol betamercaptoethanol   heated   5 min   100c fifteen microliters     samples was loaded into each well 3 mug   protein per well prestained sdspage standards biorad laboratories   standard chicken igy promega madison wis were used   molecular weight markers  elisa    assess   antibody activity   igyhp   h pylori   performed   enzymelinked immunosorbent assay elisa   akita et al    modification ninetysixwell plates were coated   h pylori wholecell lysate 500 ngwell after blocking   1 wtvol bovine serum albumin 100 mul   igyhp 1 mgml was added using   twofold serial dilution   plates were   washed   phosphatebuffered saline pbstween 005 tween 20   pbs ph 72   incubated   1 h after   addition   alkaline phosphataseconjugated goat antichicken igy promega   plates were washed   pbstween   disodium pnitrophenyl phosphate sigma was added   substrate   each well after incubation   10 min   reaction was stopped   addition   3 m naoh   absorbance was measured   405 nm using   microplate reader multiskan ms thermo labsystems helsinki finland  heat acid   pepsin stability   igyhp  igyhp solutions were incubated   0 4 10 25 35 60 70 80   90c   10 min   heattreated igyhp was cooled   an ice bath     ph stability test   phs   igyhp solutions were adjusted     desired ph ph 2   8   naoh   hcl   solutions were incubated   37c   4 h     each igyhp solution was neutralized     pepsin stability tests   phs     igyhp solutions were adjusted   ph 2 ph 4   ph 6 respectively igyhp solution   each ph were incubated   15 mug   pepsin sigmaml   37c   05 1 2   4 h after incubation each igyhp solution was neutralized   inactivate   pepsin   remaining antibody activity was measured   elisa following   heat ph   pepsin treatments antibody activity was represented     percentage   control  colony counting  h pylori 108 cfuml was incubated   igyhp 1   10 mgml   6 h   37oc under 10 co2   50 rpm after incubation h pylori was diluted   brucella broth via   10fold series dilution each 100 mul was inoculated onto brucella agar containing 5 volvol bovine calf serum     plate contents were incubated   37c under 10 co2   10 days   colonies were identified   h pylori   gram staining   urease oxidase   catalase activities   growth rate percentage   control was calculated   colony counting compared   results     control  urease activities  both igyhp 1   10 mgml   h pylori 108 cfuml were incubated   37c under 10 co2   6 h   50 rpm     50 mul   urea base 2 urea   003 phenol red was added   allowed   react   30 min urease activity was quantified   measuring   optical density   550 nm using   modification     method   fauchere   blaser    was represented      control  h pylori adhesion   ags cells    human gastric carcinoma cell line ags was obtained     korean cell line bank seoul korea cells 105 cellsml were cultured   rpmi 1640 medium gibco brl grand island ny supplemented   10 volvol fetal bovine serum hyclone laboratories logan utah   antibiotics 100 u   penicillinml   100 mug   streptomycinml hyclone   37c under 5 co2   24 h ags cells were checked   their h pylori colonization level     presence   absence   igyhp using scanning electron microscopy sem  sem    electron microscopy investigation   bacterial adhesion 300 mul   preincubated igyhp 10 mgml   h pylori 108 cfuml was added     ags cells     chamber slide nalge nunc international naperville ill after incubation   4 h   chamber slide was washed   pbs   fixed   25 volvol glutaraldehyde   24 h after washing   pbs   material was postfixed   1 oso4   60 min     washed twice   pbs fixed material was dehydrated through   graded ethanol series   50   95 followed   two washes   absolute ethanol   15 min dehydrated material   absolute ethanol was critical point dried     critical point drier hcp2 hitachi tokyo japan critical point dried material was mounted   an aluminum stub   coated   gold adherence   h pylori   ags cells was observed   sem s2500 hitachi  passive immunization   igyhp against h pylori infection   mongolian gerbils  mongolian gerbils 6weekold males were purchased   bio animal 21 sungnam korea   gerbils were infected   h pylori 05 ml 108 cfuml orally three times   12h intervals two weeks after inoculation immune response   infection was monitored   elisa h pyloriinfected gerbils were randomly divided into three groups   follows   h pylori infection only n  10 ii treatment   1 mg   igyhp treatmentml n  10   iii treatment   10 mg   igyhpml n  10 negative control groups were administered igyhp 1   10 mgml alone n  10 igyhp 1 ml was administered daily using an oral feeding needle   4 weeks after   gerbils were fasted   24 h   antral portion   stomach was quickly removed   used   histological examinations formalinfixed tissue was processed routinely   paraffin   stained   hematoxylin   eosin   examination   light microscopy gastric mucosal injury was classified   scored     scale   0 1 2   3 according     updated sydney system   statistical analysis    data were expressed     means  standard deviations sd   statistical significance was evaluated   students   tests p values   005 were considered statistically significant
12204960.txt 5 purification   characterization   igyhp   egg yolk  isolation   egg yolk igy using   lambdacarrageenan method followed     uf system was effective   purity     igy obtained was 913     yield   94 mg   igy per ml   egg yolk    egg yolk proteins obtained during purification   igy were analyzed using sdspage   shown   fig    igy finally purified using   uf system was pure   dissociated into heavy   light chains   64   25 kda respectively   electrophoretic patterns were   perfect accordance   commercially available igy promega fig  lane 2 after treating   egg yolk   lambdacarrageenan   number   proteins     wsf were significantly decreased these contaminating proteins were removed   salting out   19 sodium sulfate   igy preparation was concentrated   desalted using   uf system   igy   igyhp obtained   hens without     h pylori immunization respectively were examined   immunological properties   elisa   elisa titers were 640   10240   igy   igyhp respectively these results indicate   igyhp   highly specific   h pylori    heat ph   pepsin stabilities   igyhp were evaluated   elisa    igyhp was stable   40c however   60c   10 min igyhp lost approximately 20   its antibody activity   antibody activity   igyhp significantly decreased   80c   lost up   90   its activity igyhp showed broad stability between   phs 4   8 however igyhp lost 80   70   its initial activity   ph 2   3 respectively   antibody activity   igyhp   determined   elisa was almost lost when incubated   pepsin   ph 2 while about 92   99     activity remained   ph 4   6 respectively  effects   igyhp   growth   urease activity   h pylori   vitro    determine   effect   igyhp     growth   urease activity   h pylori   compared growth rates   urease activity   those     control   growth rates   h pylori were 600  95   100  108 compared   those found     control after incubation   1 mg   10 mg   igyhpml respectively  when h pylori 108 cfuml was incubated   igyhp 1   10 mgml   6 h   urease activity   h pylori was 754  85   155  74 compared         control   effect   igyhp   h pyloriinduced gastritis     mongolian gerbils model  mongolian gerbils were inoculated   h pylori two weeks after   inoculation   status   infection was confirmed   measuring   serum antibody igg against h pylori   h pyloriinfected gerbils were determined   high igg titer data   shown oral administration   10 mg   igyhpml   4 weeks     h pyloriinfected gerbils improved lymphocyte infiltration compared     found     h pylori infection group     igyhp 12  08 versus 25  05 p  001  however   group   was administered 1 mg   igyhpml showed   statistically significant difference     h pylori infection group 24  11 versus 25  05    group treated   10 mg   igyml significantly improved neutrophil infiltration 09  07 versus 23  08 p  001    was   statistically significant difference between   group treated   1 mg   igyhpml     h pylori infection group 22  05 versus 23  08    high dose   igyhp treatment decreased h pyloriinduced lymphocyte   neutrophil infiltration   gastric mucosa however   low dose   igy failed   protect gerbils   h pyloriinduced gastric mucosal injury  effect   igyhp   h pylori attachment   ags cells  figure  shows sem   ags cells   those infected   h pylori 108 cfuml     presence   absence   igyhp 10 mgml numerous rodshaped h pylori organisms attached     ags cells surfaces were observed when cells were cultured   h pylori      other hand   number   adhering h pylori organisms dramatically decreased when cells were pretreated   igyhp   fig 1  sdspage patterns   igy purified   egg yolk sdspage patterns   igy purified   egg yolk   coomassiestained sds10 page under nonreducing conditions b reducing conditions   sds10 page lanes 1 molecular size marker 2 chicken igy standard immunoglobulin promega 3 egg yolk 4 wsf after lambdacarrageenan treatment 5 igy obtained after salting out   6 final igy obtained   uf fig 2    reaction between igyhp   h pylori   reaction between igyhp   h pylori one hundred microliters   igyhp 1 mgml was added     twofold serial dilution   96well plates coated   h pylori wholecell lysate 500 ngwell     titers were measured using elisa igy was isolated     egg yolk   nonimmunized hens   igyhp was obtained   h pyloriimmunized hens fig 3  heat ph   pepsin stability   igyhp heat ph   pepsin stability   igyhp igyhp was treated   various temperatures   10 min     various phs   4 h b     pepsin 15 mulml c   ph 2 4   6   05 1 2   4 h remaining activities after   treatments were measured using elisa     expressed     percentage     initial activity fig 4  effect   igyhp     growth   urease activity   h pylori h pylori effect   igyhp     growth   urease activity   h pylori h pylori 108 cfuml was incubated     igyhp 1   10 mgml   6 h   37c under 10 co2   50 rpm after incubation bacteria were inoculated   agar plates   growth rate percentage   control was calculated   colony counting compared     control both igyhp 1   10 mgml   h pylori 108 cfuml were incubated   37oc under 10 co2   6 h   50 rpm     50 mul   urea base 2 urea003 phenol red was added   reacted   30 min urease activity was measured     spectrophotometer   550 nm     represented     percentage     control   results   shown     mean  sd     statistically significant differences     values     control p  005   p  001 respectively fig 5  effect   igyhp   h pylori effect   igyhp   h pyloriinduced gastric mucosal injury igyhp 1   10 mgml was orally administered   mongolian gerbils   4 weeks   lymphocytes   neutrophils were measured     degree   lymphocyte   neutrophil infiltration respectively   results   shown     mean  sd  statistically significant differences     values     h pylori infection group p  001 fig 6  sem findings   h pylori sem findings   h pyloriinfected ags cells     presence   absence   igyhp   ags cells b ags cells infected   h pylori 108 cfuml c ags cells infected   h pylori 108 cfuml pretreated   igyhp 10 mgml table 1  summary   yield   purity   igy   egg yolk
12204960.txt 6   present study demonstrates   igyhp prepared     egg yolk   hens immunized   h pylori   effective     treatment   h pylori infections h pylori infections   widespread   humans   although   can   cured using antimicrobial therapy   largescale use   antibiotics leads     emergence   antibioticresistant strains  moreover antimicrobial therapeutic cures   h pylori infections     lead   immunity   reinfection      emergence   antibioticresistant strains can increase failure therapy   relapse rates  consequently   have been tremendous efforts   seek alternatives   antibioticbased therapies       widely available means   treating suppressing   preventing h pylori infections without drug resistance problems recent work   several laboratories using several animal models has shown   immunization   defined native   recombinant antigens   h pylori can protect against h pylori infections    mechanisms   protection   still poorly understood although prophylactic   therapeutic immunization has been successful   animal models efficacy data   humans   still lacking     other hand treatment   h pylori infection   oral administration   active antibodies specific   h pylori may have merit due     antibody being recognized   h pylori thus inhibiting adhesion     bacterium   human epithelial cells   efficiently many studies have shown   egg yolk   an immunized hen has an antibody capable   specific recognition   an abundant quantity     therefore economical    estimated   1 ml     egg yolk 15 ml per egg contains about 94 mg   igy   hen lays about 250 eggs about 4000 ml   egg yolk     year thus   eggs laid   an immunized hen     year would yield 40 g   igy oral administration   igy   chicken egg yolk has been used successfully   many researchers   preventing many intestinal diseases such   those caused   enterotoxigenic e coli    human rotavirus  sugitakonishi et al  reported   igy obtained   hens immunized     mixture   formalintreated pathogenic bacteria inhibited   growth   pseudomonas aeruginosa   production   staphylococcus aureus enterotoxin     adhesion   salmonella typhimurium serovar enteritidis   cultured human intestinal cells were also inhibited igy antibodies inhibited   colonization   teeth   streptococcus mutans thus preventing plaque formation   humans  however   has been   report   far     use   igy     prevention   treatment   h pylori infections     study igyhp obtained   hens immunized   h pylori wholecell lysate dramatically inhibited   growth   h pylori   vitro     antibody igy had   specific effect   inhibition   bacterial growth would occur   seems clear     observations using gerbil models   igyhp decreased h pyloriinduced gastric mucosal injury   determined     degree   lymphocyte   neutrophil infiltration therefore   therapeutic value   orally administered igyhp against   experimental model   gerbils lies   its ability   inhibit   bacterial organism   convincing evidence   support     specificity   these antibodies comes   inhibition   h pylori attachment   ags cells   confirmed   sem although   mechanisms     igyhp prevented h pylori colonization   yet   elucidated   results suggest   igyhp would inhibit h pylori adherence properties   interest   igyhp used     study significantly inhibited urease activity   relationship between inhibitions   urease activity   adhesion properties needs     clarified     study igyhp seems   have two properties inhibiting adhesion     bacterium   gastric epithelial cells   demonstrating powerful ureaseinhibiting activity   practical application   igyhp together   food   pharmaceutical materials   treat h pylori infection   stability   igyhp toward heat acid   pepsin was studied   measuring   remaining activity   elisa immunologically igyhp stayed active   60c   10 min suggesting   pasteurization can   applied   sterilize   product   fortification   food products     immunoglobulin together   its higher productivity   effectiveness would significantly decrease   activities   h pylori infections   conclusion   encouraging results     study indicate     igyhp obtained   hens immunized   h pylori may provide   novel approach     management   h pylori infections   humans however many problems remain unsolved     clinical application such     effect   igyhp   humans   persistence     effect   igyhp after cessation     application     potential   eradicating an established infection
12204960.txt 7 
